# A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body

> **NCT06492135** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 30 (actual)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** survodutide

## Key facts

- **NCT ID:** NCT06492135
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-12
- **Primary completion:** 2025-04-15
- **Final completion:** 2025-04-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06492135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06492135, "A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06492135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*